Long-Term Efficacy and Safety in COMFORT-II, a Phase 3 Study Comparing Ruxolitinib with Best Available Therapy for the Treatment of Myelofibrosis: 5-Year Final Study Results

被引：0

作者：

Harrison, Claire N. ^{[1
]}

Vannucchi, Alessandro M. ^{[2
]}

Kiladjian, Jean-Jacques ^{[3
,4
]}

Al-Ali, Haifa Kathrin ^{[5
]}

Gisslinger, Heinz ^{[6
]}

Knoops, Laurent ^{[7
,8
]}

Cervantes, Francisco ^{[9
]}

Jones, Mark M. ^{[10
]}

Sun, Kang ^{[10
]}

Descamps, Laurence ^{[11
]}

Stalbovskaya, Viktoriya ^{[12
]}

Gopalakrishna, Prashanth ^{[12
]}

Barbui, Tiziano ^{[13
]}

机构：

[1] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England

[2] Univ Florence, Florence, Italy

[3] Hop St Louis, Paris, France

[4] Univ Paris Diderot, Paris, France

[5] Univ Leipzig, D-04109 Leipzig, Germany

[6] Med Univ Vienna, Vienna, Austria

[7] Clin Univ St Luc, B-1200 Brussels, Belgium

[8] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium

[9] Univ Barcelona, IDIBAPS, Hosp Clin, Barcelona, Spain

[10] Incyte Corp, Wilmington, DE USA

[11] Novartis Pharma SAS, Rueil Malmaison, France

[12] Novartis Pharma AG, Basel, Switzerland

[13] Hosp Papa Giovanni XXIII & Res Fdn, Bergamo, Italy

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1)
Imafuku, Shinichi
Nakagawa, Hidemi
Igarashi, Atsuyuki
Morita, Akimichi
Okubo, Yukari
Sano, Shigetoshi
Tada, Yayoi
Nemoto, Osamu
Rozzo, Stephen J.
Kawamura, Masaki
Ohtsuki, Mamitaro
JOURNAL OF DERMATOLOGY, 2021, 48 (06): : 844 - 852
[42] LONG-TERM EVALUATION OF SECUKINUMAB 150MG IN ANKYLOSING SPONDYLITIS: 5-YEAR END-OF-STUDY EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL
Beake, Jess
RHEUMATOLOGY, 2020, 59 : 144 - 144
[43] Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study
Baraliakos, Xenofon
Braun, Juergen
Deodhar, Atul
Poddubnyy, Denis
Kivitz, Alan
Tahir, Hasan
Van den Bosch, Filip
Delicha, Evie-Maria
Talloczy, Zsolt
Fierlinger, Anke
RMD OPEN, 2019, 5 (02):
[44] Results From the 208-Week (4-Year) Follow-Up of the RESPONSE Trial, a Phase 3 Study Comparing Ruxolitinib With Best Available Therapy for the Treatment of Polycythemia Vera
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (02) : 6 - 8
[45] Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
Nakaoka, Yoshikazu
Isobe, Mitsuaki
Tanaka, Yoshiya
Ishii, Tomonori
Ooka, Seido
Niiro, Hiroaki
Tamura, Naoto
Banno, Shogo
Yoshifuji, Hajime
Sakata, Yasushi
Kawakami, Atsushi
Atsumi, Tatsuya
Furuta, Shunsuke
Kohsaka, Hitoshi
Suzuki, Katsuya
Hara, Ryoki
Maejima, Yasuhiro
Tsukamoto, Hiroshi
Takasaki, Yoshinari
Yamashita, Katsuhisa
Okada, Norihiro
Yamakido, Shinji
Takei, Syuji
Yokota, Shumpei
Nishimoto, Norihiro
RHEUMATOLOGY, 2020, 59 (09) : 2427 - 2434
[46] Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
Nitti, Victor W.
Ginsberg, David
Sievert, Karl-Dietrich
Sussman, David
Radomski, Sidney
Sand, Peter
De Ridder, Dirk
Jenkins, Brenda
Magyar, Andrew
Chapple, Christopher
JOURNAL OF UROLOGY, 2016, 196 (03): : 791 - 800
[47] Phase III Long Term Extension Study of Ponesimod in Relapsing Multiple Sclerosis: 5-Year Efficacy Results
Lublin, F. D.
Singh, A.
Ait-Tihyaty, M.
Raghavan, N.
Pirozek-Lawniczek, M.
Sidorenko, T.
Kappos, L.
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 58 - 58
[48] Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST)
Vichinsky, Elliott
El-Beshlawy, Amal
Al Zoebie, Azzam
Kamdem, Annie
Koussa, Suzanne
Chotsampancharoen, Thirachit
Bruederle, Andreas
Gilotti, Geralyn
Han, Jackie
Elalfy, Mohsen
PEDIATRIC BLOOD & CANCER, 2017, 64 (09)
[49] Long-term Efficacy and Safety of Intra-articular Sprifermin in Patients with Knee Osteoarthritis: Results from the 5-Year Forward Study
Eckstein, Felix
Hochberg, Marc
Guehring, Hans
Moreau, Flavie
Ona, Victor
Bihlet, Asger
Byrjalsen, Inger
Andersen, Jeppe
Daelken, Benjamin
Guenther, Oliver
Ladel, Christoph
Michaelis, Martin
Conaghan, Philip G.
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[50] SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY
Ashina, Messoud
Goadsby, Peter J.
Reuter, Uwe
Silberstein, Stephen
Dodick, David W.
Xue, Fei
Zhang, Feng
Cheng, Sunfa
Chou, Denise E.
Lima, Gabriel Paiva da Silva
CEPHALALGIA, 2020, 40 : 60 - 61

← 1 2 3 4 5 →